ISO 17593-2022 PDF

ISO 17593-2022 PDF

Clinical laboratory testing and in vitro medical devices-Requirements for in vitro monitoring systems for self-testing of oral anticoagulant therapy

$145.50 $291.00 -50%
Product Code: ISO 17593
Stock In Stock
Edition: 2ND
Published: 03/2022
Number of Pages: 60
File Size: 1 file, 5 Bytes

Available Options

Product Description

Clinical laboratory testing and in vitro medical devices — Requirements for in vitro monitoring systems for self-testing of oral anticoagulant therapy

Introduction: Oral-anticoagulation monitoring systems are in vitro diagnostic (IVD) medical devices that measure prothrombin time in fresh, untreated human blood specimens. Prothrombin time is an indicator of the ability of blood to clot. IVD medical devices for self-testing of oral-anticoagulation therapy are used predominantly by individuals who have heart valve replacements, or who are suffering from atrial fibrillation or deep vein thrombosis and are receiving oral anticoagulant therapy with vitamin K antagonist medicines (e.g. warfarin). Patients must maintain the level of anticoagulant in the blood high enough to reduce thrombin formation, yet low enough to avoid excessive bleeding. An oral- anticoagulation monitoring system allows the user to monitor anticoagulation therapy and take action to control the level of anticoagulant present in the blood. This document applies to oral-anticoagulation monitoring systems to be used by lay persons. The primary objectives are to establish requirements for oral-anticoagulation monitoring systems that will enable lay persons to achieve acceptable performance, and to specify procedures for manufacturers and other interested parties to demonstrate conformance of such systems to the requirements stated in this document. Performance criteria for oral-anticoagulation monitoring systems were established, based on the state- of-the-art, which has been shown to offer significant benefit to patients [31]. The criteria are given in terms of “system accura

Scope: This document specifies requirements for in vitro measuring systems for self-monitoring of vitamin-K antagonist oral anticoagulation therapy, including performance, quality assurance and user training and procedures for the validation of performance by the intended users under actual and simulated conditions of use. This document applies solely to prothrombin time measuring systems used by lay persons for monitoring their own vitamin-K antagonist oral anticoagulation therapy, and which report results as international normalized ratios (INR). This document is applicable to manufacturers of such systems and those other organizations (e.g. regulatory authorities and conformity assessment bodies) having the responsibility for assessing the performance of these systems. This document is not applicable to: — in vitro measuring systems for coagulation quantities assessing vitamin-K antagonist oral anticoagulation therapy used by physicians or healthcare providers; — non-vitamin-K antagonist oral anticoagulation therapy (e.g. dabigatran); — a comprehensive evaluation of all possible factors that can affect the performance of these systems; — the medical aspects of oral-anticoagulation therapy.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good
ISO 17593-2022 PDF

ISO 17593-2022 PDF

$145.50 $291.00